Real-world evidence of the safety and effectiveness of regorafenib in Taiwanese patients with metastatic colorectal cancer: CORRELATE Taiwan.
CONCLUSIONS: The safety and effectiveness of regorafenib in this real-world study was generally consistent with the known efficacy and safety profile in Asian patients in clinical trials.
TRIAL REGISTRATION: NCT02042144.
PMID: 33422398 [PubMed - as supplied by publisher]
Source: J Formos Med Assoc - Category: General Medicine Authors: Yeh KH, Yang TS, Hsu TC, Tzu-Liang Chen W, Chen HH, Teng HW, Lin BW, Kuan FC, Chiang FF, Duann CW, Li YS, Lin MT, Fiala-Buskies S, Ducreux M, Wang JY Tags: J Formos Med Assoc Source Type: research
More News: Cancer | Cancer & Oncology | Clinical Trials | Colorectal Cancer | General Medicine | Science | Skin | Study | Taiwan Health